“…Indeed, reduced placental expression of LGALS13 (Galectin 13), a member of the glycan-binding proteins that regulate innate and adaptive immune responses, was found in women with preeclampsia ( Than et al, 2014 ). Similarly, the expression of SDC1, NPPB (natriuretic peptide B), GDF15 (growth differentiation factor 15), and ADAMTS6 (ADAM metallopeptidase with thrombospondin type 1 motif 6) all had a lower expression in our experimental exposures, and all are lower in preeclampsia ( Junus et al, 2014 ; Chen et al, 2016 ; Gandley et al, 2016 ; Jiang et al, 2020 ). In contrast, our data are inconsistent with respect to the expression of PAPPA2, a regulator of trophoblast invasion and migration, or MNDA (myeloid cell nuclear differentiation antigen), which exhibited a lower expression level in our paradigms but is elevated in placentas from women with preeclampsia ( Wagner et al, 2011 ; Kolialexi et al, 2017 ; Neuman et al, 2020 ).…”